1-11 of 11
Jeanne M. Palmer, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rationale for and Results of a Phase I Study of the TGF-β 1/3 Inhibitor AVID200 in Subjects with Myelofibrosis: MPN-RC 118 Trial

John Mascarenhas, MD, Heidi E. Kosiorek, MS, Lilian Varricchio, PhD, Rupali Bhave, MD, Andrew T. Kuykendall, MD, Rami Komrokji, MD, Aaron T. Gerds, MDMS, Jeanne M. Palmer, MD, Amelia R. Gabler, Lonette Sandy, Anna Rita Migliaccio, PhD, Mohamed E Salama, MD, Rona Singer Weinberg, PhD, Maureen O'Connor-McCourt, PhD, Gilles Tremblay, PhD, Paul I. Nadler, MD, Amylou C. Dueck, PhD, Ruben A. Mesa, MD FACP, Ronald Hoffman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–8.
https://doi.org/10.1182/blood-2020-140830
Published: 2020
Journal Articles

Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care

Blake T. Langlais, MS, Carolyn Mead-Harvey, MS, Heidi E. Kosiorek, MS, Gina L. Mazza, PhD, Ruben Mesa, MD, Jeanne M. Palmer, MD, Amylou C. Dueck, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-143172
Published: 2020
Journal Articles

Ropeginterferon Demonstrates Safety and Efficacy in Myelofibrosis: Pilot Study Results

Jeanne M. Palmer, MD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, John Camoriano, MD, Craig Zimmerman, PhD, Ruben Mesa, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23.
https://doi.org/10.1182/blood-2020-138934
Published: 2020
Journal Articles

Duration of Response to Luspatercept in Patients (Pts) Requiring Red Blood Cell (RBC) Transfusions with Myelofibrosis (MF) - Updated Data from the Phase 2 ACE-536-MF-001 Study

Aaron T. Gerds, MDMS, Alessandro M. Vannucchi, MD, Francesco Passamonti, Marina Kremyanskaya, Jason Gotlib, Jeanne M. Palmer, MD, Kelly McCaul, Vincent Ribrag, MD, Adam J. Mead, MD PhD, Claire Harrison, DM, FRCP, FRCPath, Ruben Mesa, MD, Jean-Jacques Kiladjian, Giovanni Barosi, Torsten G. Gerike, Jeevan K. Shetty, Joseph Pariseau, Gabriel Miranda, Martin Schwickart, Ana Carolina Giuseppi, Jennie Zhang, Jay T. Backstrom, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 47–48.
https://doi.org/10.1182/blood-2020-137265
Published: 2020
Journal Articles

Molecular Response Patterns in Hydroxyurea (HU)-Resistant or Intolerant Polycythemia Vera (PV) during Treatment with Idasanutlin: Results of an Open-Label, Single-Arm Phase 2 Study

Francesco Passamonti, Kate Burbury, MBBS, FRACP, FRCPA, DPhil, Tarec Christoffer El-Galaly, Aaron T. Gerds, MDMS, Vikas Gupta, MD FRCP, FRCPath, Brian Higgins, Ling-Yuh Huw, PhD, Margherita Maffioli, MD, Ruben Mesa, MD, Jeanne M. Palmer, MD, Alessandro Rambaldi, MD, David M Ross, MBBS, PhD FRACP, FRCPA, Alessandro M. Vannucchi, MD, Abdulraheem Yacoub, MD, John Mascarenhas, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–40.
https://doi.org/10.1182/blood-2020-136135
Published: 2020
Journal Articles

Safety and Efficacy of Idasanutlin in Patients (pts) with Hydroxyurea (HU)-Resistant/Intolerant Polycythemia Vera (PV): Results of an International Phase II Study

John Mascarenhas, MD, Brian Higgins, Doreen Anders, Kate Burbury, MD, Tarec Christoffer El-Galaly, Aaron T. Gerds, MDMS, Vikas Gupta, MD FRCP, FRCPath, Bruno Kovic, Margherita Maffioli, MD, Ruben Mesa, MD, Jeanne M. Palmer, MD, Francesco Passamonti, MD, Alessandro Rambaldi, MD, David M Ross, MBBS, PhD FRACP, FRCPA, Alessandro M. Vannucchi, MD, Abdulraheem Yacoub, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–31.
https://doi.org/10.1182/blood-2020-135868
Published: 2020
Journal Articles

Efficacy of Venetoclax Plus Hypomethylating Agent in Blast Phase Myeloproliferative Neoplasm

Erika Morsia, MD, Naseema Gangat, MBBS, James M. Foran, MD, Jeanne M. Palmer, MD, Michelle A Elliott, MD, Ayalew Tefferi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-134701
Published: 2020
Journal Articles

Pre- Transplant Ferritin Predicts Overall Survival and Non-Relapse Mortality in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis

Xavier A Andrade-Gonzalez, MD, Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Mrinal M. Patnaik, MDMBBS, Jeanne M. Palmer, MD, Mohamed A. Kharfan-Dabaja, MDMBA, Mark Litzow, MD, Mithun Vinod Shah, MD PhD, William J Hogan, MB, BCh, Hassan B. Alkhateeb, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-141414
Published: 2020
Journal Articles

Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients

Jeanne M. Palmer, MD, Carolyn Mead-Harvey, MS, Claire Harrison, DM, FRCP, FRCPath, Amylou C. Dueck, PhD, Ryan Eckert, MS, Heidi E. Kosiorek, MS, Pablo Muxi, MD, Naveen Pemmaraju, MD, Guillermo Ruiz Arguelles, Alessandro M. Vannucchi, MD, Vikas Gupta, MD FRCP, FRCPath, John Mascarenhas, MD, Kerry Taylor, MBBS(Hons) FRACP FRCPA, Krisstina L. Gowin, DO, Holly L. Geyer, MD, Kazuya Shimoda, MD PhD, Jean-Jacques Kiladjian, MD PhD, Norio Komatsu, MD PhD, Grace Kam Li Shan, MBBS, Virginia Abello, MD, David Gomez-Almaguer, MD, Robyn M. Scherber, MD, Qian Jiang, MD, Xuelan Zuo, Jennifer Huberty, PhD, Lesley Anderson, MD, Blake T. Langlais, MS, Ann Brazeau, Michelle Woehrle, Michael J. Mauro, MD, Ruben Mesa, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-138953
Published: 2020
Journal Articles

Validation of a Modified Version of the Myeloproliferative Neoplasm Symptom Assessment Form Total Symptom Score (MPN-SAF TSS)

Blake T. Langlais, MS, Heidi E. Kosiorek, MS, Gina L. Mazza, PhD, Carolyn Mead-Harvey, MS, Richard Butterfield, III, Jeanne M. Palmer, MD, Ruben Mesa, MD, Amylou C. Dueck, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-142838
Published: 2020
Journal Articles

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Nandita Khera, MD MPH, Navneet S. Majhail, MD MS, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Mahmoud Aljurf, MD, Görgün Akpek, MD MHS, Yoshiko Atsuta, MDPhD, Sara Beattie, BSc(Hons), Christopher N. Bredeson, MD MSc, FRCPC, Linda J. Burns, MD, Allen R. Chen, MD PhD MHS, Jason Dehn, MPH, CHTC, César O Freytes, MD, Vikas Gupta, MD FRCP, FRCPath, Gregory A. Hale, MD, Yoshihiro Inamoto, MD PhD, Hillard M. Lazarus, MD, Charles F. LeMaistre, MD, Jeanne M. Palmer, MD, Kristjan Paulson, MD FRCPC, Raquel M. Schears, MD MPH, FACEP, Amir Steinberg, MD, David Szwajcer, MD FRCPC, John R. Wingard, MD, Baldeep Wirk, MD, William A. Wood, MD MPH, Steven Joffe, MD MPH, Theresa Hahn, PhD, Fausto R. Loberiza, MD MS, Stephanie J. Lee, MD MPH
Journal: Blood
Blood (2014) 124 (21): 209.
https://doi.org/10.1182/blood.V124.21.209.209
Published: 2014